Cargando…
Thrombotic Thrombocytopenic Purpura in a Patient with Interferon Treated Hepatitis C Successfully Treated with Rituximab
Thrombotic thrombocytopenic purpura (TTP) is a life threatening condition associated with formation of platelet thrombi. Deficiency of ADAM TS 13 with presence of inhibitory anti-ADAM TS 13 Immunoglobulin G antibody is seen in patients with acquired TTP. TTP in patients on interferon therapy for chr...
Autores principales: | Poddar, Nishant, Wang, Jen C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
PAGEPress Publications
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3719105/ https://www.ncbi.nlm.nih.gov/pubmed/23888238 http://dx.doi.org/10.4081/hr.2013.e2 |
Ejemplares similares
-
Thrombotic Thrombocytopenic Purpura Treated with Rituximab Associated with Primary Sjögren's Syndrome and Primary Hypothyroidism
por: Okumura, Taiki, et al.
Publicado: (2019) -
Thrombotic thrombocytopenic purpura treated with rituximab in systemic lupus erythematosus
por: Karimifar, Mansoor
Publicado: (2012) -
Successful treatment of plasma exchange-refractory thrombotic thrombocytopenic purpura with rituximab: A case report
por: Chen, Jian, et al.
Publicado: (2020) -
Delayed Thrombotic Complications in a Thrombotic Thrombocytopenic Purpura Patient Treated With Caplacizumab
por: Cilla, Nicolas, et al.
Publicado: (2020) -
A case of acquired thrombotic thrombocytopenic purpura induced by acute severe hepatitis E: successfully treated by plasma exchange and rituximab
por: Ou, Yingwei, et al.
Publicado: (2023)